Supernus Pharmaceuticals SUPN Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's work in process?
- Supernus Pharmaceuticals (SUPN) reported work in process of $36.05M in Q1 2026.
- How has Supernus Pharmaceuticals's work in process changed year-over-year?
- Supernus Pharmaceuticals's work in process increased by 92.9% year-over-year, from $18.69M to $36.05M.
- What is the long-term trend for Supernus Pharmaceuticals's work in process?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's work in process has grown at a 26.8% compound annual growth rate (CAGR), from $8.99M to $29.44M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.